Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Turkcell
TKC
$4.79B
| $678K | ﹤0.01% |
141,050
+111,750
| +381% | +$525K |
|
2627
Daily Journal
DJCO
$778M
| $677K | ﹤0.01% |
1,987
+887
| +81% | +$277K |
|
2628
Ebang International Holdings
EBON
$12.3M
| $676K | ﹤0.01% |
44,213
| – | – |
|
2629
Comstock Holding Companies
CHCI
$153M
| $673K | ﹤0.01% |
151,782
-282
| -0.2% | -$1.22K |
|
2630
FinWise Bancorp
FINW
$195M
| $673K | ﹤0.01% |
47,000
+31,100
| +196% | +$332K |
|
2631
Similarweb
SMWB
$658M
| $672K | ﹤0.01% |
126,000
+90,100
| +251% | +$472K |
|
|
NAGE
2632
Niagen Bioscience
NAGE
$247M
| $671K | ﹤0.01% |
469,302
+24,390
| +5% | +$34K |
|
|
WKME
2633
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $670K | ﹤0.01% |
62,800
+41,500
| +195% | +$391K |
|
2634
Global X Artificial Intelligence & Technology ETF
AIQ
$11B
| $669K | ﹤0.01% |
+21,461
| New | +$614K |
|
2635
Five Point Holdings
FPH
$375M
| $666K | ﹤0.01% |
216,800
+135,100
| +165% | +$354K |
|
2636
Wolverine World Wide
WWW
$1.55B
| $666K | ﹤0.01% |
+74,900
| New | +$637K |
|
|
QXO
2637
QXO Inc
QXO
$17.4B
| $666K | ﹤0.01% |
4,863
+1,080
| +29% | +$49K |
|
2638
International Flavors & Fragrances
IFF
$21.9B
| $664K | ﹤0.01% |
+8,200
| New | +$593K |
|
2639
Smith-Midland
SMID
$152M
| $664K | ﹤0.01% |
+16,800
| New | +$451K |
|
2640
MicroSectors U.S. Big Oil 3x Leveraged ETNs due Feb 17 2045
NRGU
$19.2M
| $663K | ﹤0.01% |
+1,600
| New | +$679K |
|
2641
Usio Inc
USIO
$64M
| $662K | ﹤0.01% |
385,141
+23,800
| +7% | +$43.6K |
|
2642
Schwab 5-10 Year Corporate Bond ETF
SCHI
$11.5B
| $661K | ﹤0.01% |
29,400
+12,400
| +73% | +$266K |
|
2643
Seadrill
SDRL
$2.7B
| $661K | ﹤0.01% |
13,979
-3,891
| -22% | -$165K |
|
2644
Stoneridge
SRI
$213M
| $660K | ﹤0.01% |
33,719
-4,400
| -12% | -$76.4K |
|
2645
Minerva Neurosciences
NERV
$199M
| $659K | ﹤0.01% |
107,200
+13,000
| +14% | +$74.3K |
|
2646
iShares ESG Aware MSCI EAFE ETF
ESGD
$12.3B
| $657K | ﹤0.01% |
+8,700
| New | +$616K |
|
2647
Chicago Rivet & Machine Co
CVR
$10.3M
| $656K | ﹤0.01% |
38,610
-500
| -1% | -$8.47K |
|
2648
Global X MLP & Energy Infrastructure ETF
MLPX
$3.53B
| $656K | ﹤0.01% |
14,700
+2,006
| +16% | +$87.1K |
|
|
MACK
2649
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $656K | ﹤0.01% |
+48,900
| New | +$618K |
|
2650
Pyxis Oncology
PYXS
$236M
| $655K | ﹤0.01% |
364,150
+147,899
| +68% | +$253K |
|
Similar funds
Renaissance Technologies's Q4 2023 Portfolio in Review
As of Q4 2023, Renaissance Technologies held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Renaissance Technologies's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Renaissance Technologies fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Renaissance Technologies's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Renaissance Technologies opened 702 new positions and closed 633 in Q4 2023.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.